Cancer Epidemiology
Volume 34, Issue 4 , Pages 400-404 , August 2010

Prenatal exposure to medicines and the risk of childhood brain tumor

  • Karin Stålberg

      Affiliations

    • Department of Women's and Children's Health, Uppsala University, S-751 85 Uppsala, Sweden
    • Corresponding Author InformationCorresponding author at: Department of Women's and Children's Health, Obstetrics and Gynaecology, Uppsala University, S-751 85 Uppsala, Sweden. Tel.: +46 18 6115765; fax: +46 18 559775.
    • ,
  • Bengt Haglund

      Affiliations

    • Department of Women's and Children's Health, Uppsala University, S-751 85 Uppsala, Sweden
    • Center for Epidemiology, National Board of Health and Welfare, S-106 30 Stockholm, Sweden
    • ,
  • Bo Strömberg

      Affiliations

    • Department of Women's and Children's Health, Uppsala University, S-751 85 Uppsala, Sweden
    • ,
  • Helle Kieler

      Affiliations

    • Centre for Pharmacoepidemiology, Department of Medicine, Karolinska Institutet, S-171 77 Stockholm, Sweden

,Accepted 27 April 2010.

References 

  1. Olesen C, Sorensen HT, de Jong-van den Berg L, Olsen J, Steffensen FH. Prescribing during pregnancy and lactation with reference to the Swedish classification system. A population-based study among Danish women. The Euromap Group. Acta Obstet Gynecol Scand. 1999;78(8):686–692
  2. Engeland A, Bramness JG, Daltveit AK, Ronning M, Skurtveit S, Furu K. Prescription drug use among fathers and mothers before and during pregnancy. A population-based cohort study of 106,000 pregnancies in Norway 2004–2006. Br J Clin Pharmacol. 2008;65(5):653–660
  3. Schwartzbaum JA. Influence of the mother's prenatal drug consumption on risk of neuroblastoma in the child. Am J Epidemiol. 1992;135(12):1358–1367
  4. Cook MN, Olshan AF, Guess HA, Savitz DA, Poole C, Blatt J, et al. Maternal medication use and neuroblastoma in offspring. Am J Epidemiol. 2004;159(8):721–731
  5. Cordier S, Iglesias MJ, Le Goaster C, Guyot MM, Mandereau L, Hemon D. Incidence and risk factors for childhood brain tumors in the Ile de France. Int J Cancer. 1994;59(6):776–782
  6. Schuz J, Weihkopf T, Kaatsch P. Medication use during pregnancy and the risk of childhood cancer in the offspring. Eur J Pediatr. 2007;166(5):433–441
  7. Olshan AF, Smith JC, Bondy ML, Neglia JP, Pollock BH. Maternal vitamin use and reduced risk of neuroblastoma. Epidemiology. 2002;13(5):575–580
  8. Preston-Martin S, Pogoda JM, Mueller BA, Lubin F, Holly EA, Filippini G, et al. Prenatal vitamin supplementation and risk of childhood brain tumors. Int J Cancer Suppl. 1998;11:17–22
  9. Carozza SE, Olshan AF, Faustman EM, Gula MJ, Kolonel LN, Austin DF, et al. Maternal exposure to N-nitrosatable drugs as a risk factor for childhood brain tumours. Int J Epidemiol. 1995;24(2):308–312
  10. Barlow L, Westergren K, Holmberg L, Talback M. The completeness of the Swedish Cancer Register: a sample survey for year 1998. Acta Oncol. 2009;48(1):27–33
  11. Mattsson B, Wallgren A. Completeness of the Swedish Cancer Register. Non-notified cancer cases recorded on death certificates in 1978. Acta Radiol Oncol. 1984;23(5):305–313
  12. Cnattingius S, Ericson A, Gunnarskog J, Kallen B. A quality study of a medical birth registry. Scand J Soc Med. 1990;18(2):143–148
  13. Stalberg K, Haglund B, Axelsson O, Cnattingius S, Pfeifer S, Kieler H. Prenatal X-ray exposure and childhood brain tumours: a population-based case–control study on tumour subtypes. Br J Cancer. 2007;97(11):1583–1587
  14. Kuijten RR, Bunin GR, Nass CC, Meadows AT. Gestational and familial risk factors for childhood astrocytoma: results of a case–control study. Cancer Res. 1990;50(9):2608–2612
  15. Michalek AM, Buck GM, Nasca PC, Freedman AN, Baptiste MS, Mahoney MC. Gravid health status, medication use, and risk of neuroblastoma. Am J Epidemiol. 1996;143(10):996–1001
  16. Cardy AH, Little J, McKean-Cowdin R, Lijinsky W, Choi NW, Cordier S, et al. Maternal medication use and the risk of brain tumors in the offspring: The SEARCH international case–control study. Int J Cancer. 2006;118(5):1302–1308
  17. McKean-Cowdin R, Pogoda JM, Lijinsky W, Holly EA, Mueller BA, Preston-Martin S. Maternal prenatal exposure to nitrosatable drugs and childhood brain tumours 10.1093/ije/dyg050. Int J Epidemiol. 2003;32(2):211–217
  18. Headley J, Northstone K, Simmons H, Golding J. Medication use during pregnancy: data from the Avon Longitudinal Study of Parents and Children. Eur J Clin Pharmacol. 2004;60(5):355–361
  19. Jurek AM, Greenland S, Maldonado G, Church TR. Proper interpretation of non-differential misclassification effects: expectations vs observations 10.1093/ije/dyi060. Int J Epidemiol. 2005;34(3):680–687
  20. Brooks DR, Mucci LA, Hatch EE, Cnattingius S. Maternal smoking during pregnancy and risk of brain tumors in the offspring. A prospective study of 1.4 million Swedish births. Cancer Causes Control. 2004;15(10):997–1005
  21. Goon PKY, Stonelake PS, Lip GYH. Hypertension, anti-hypertensive therapy and neoplasia. Curr Pharm Des. 2007;13(25):2539–2544
  22. Robbiano L, Martelli A, Allavena A, Mazzei M, Gazzaniga GM, Brambilla G. Formation of the N-nitroso derivatives of six {beta}-adrenergic-blocking agents and their genotoxic effects in rat and human hepatocytes. Cancer Res. 1991;51(9):2273–2279
  23. Brambilla G, Martelli A. Genotoxicity and carcinogenicity studies of antihypertensive agents. Mutat Res/Rev Mutat Res. 2006;612(2):115–149

PII: S1877-7821(10)00080-9

doi: 10.1016/j.canep.2010.04.018

Cancer Epidemiology
Volume 34, Issue 4 , Pages 400-404 , August 2010

Article Tools